Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.
about
Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg?10% liquid human immunoglobulin (KIOVIG(®)) for immunomodulation in autoimmune disorders.
P2860
Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Intravenous immunoglobulin-med ...... lopment of an IVIG substitute.
@en
type
label
Intravenous immunoglobulin-med ...... lopment of an IVIG substitute.
@en
prefLabel
Intravenous immunoglobulin-med ...... lopment of an IVIG substitute.
@en
P2093
P2860
P1476
Intravenous immunoglobulin-med ...... lopment of an IVIG substitute.
@en
P2093
Hyeong-jwa Choi
Jin-Yeon Park
Miglena G Prabagar
Young-Sun Kang
P2860
P2888
P304
P356
10.1007/S10238-013-0255-4
P577
2013-09-01T00:00:00Z
P6179
1021287893